Continental Advisors LLC Boston Scientific Corp Transaction History

Continental Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $43,019 - $50,703	-1,130 Reduced 10.62%	9,512 $404,000
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $45,765 - $50,926	-1,110 Reduced 9.45%	10,642 $462,000
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $88,734 - $101,752	-2,300 Reduced 16.37%	11,752 $503,000
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $99,876 - $122,466	-2,900 Reduced 17.11%	14,052 $537,000
Q4 2019 Feb 10, 2020	SELL	$37.87 - $45.37 $214,003 - $256,385	-5,651 Reduced 25.0%	16,952 $767,000
Q3 2019 Oct 28, 2019	SELL	$40.31 - $43.45 $56,595 - $61,003	-1,404 Reduced 5.85%	22,603 $920,000
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $122,184 - $150,430	-3,500 Reduced 12.72%	24,007 $1.03 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $973,905 - $1.21 Million	-29,593 Reduced 51.83%	27,507 $1.06 Million
Q4 2017 Feb 13, 2018	SELL	$24.79 - $29.8 $247,900 - $298,000	-10,000 Reduced 14.9%	57,100 $1.42 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $1.76 Million - $1.96 Million	67,100	67,100 $1.96 Million

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.